CEO North America > CEO Life > Health
As life continues to go on after the COVID-19 pandemic, two new studies from the Centers for Disease Control and...
A blood-based screening test detected colorectal cancer in more than 83% of the patients with the disease, according to a...
Novo Nordisk's new weight loss drug, amycretin, is showing greater potential than Wegovy for weight loss, as its trial resulted...
A seven-year study of people with myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS, done by the National Institutes of Health found...
Smoking tobacco changes the immune system, putting people at greater risk of diseases and infection, and the effect can last...
Cancer rates are rising, with diagnoses expected to increase 55% globally between 2022 and 2045, going from about 19.9 million...
This year saw 21.3 million people sign up for health insurance on Affordable Care Act marketplaces, marking a 30.7% annual increase,...
On Monday, the Biden administration announced that the U.S. government will once again be offering free at-home Covid-19 testing kits...
The days of yellow and brown smoke transforming the likes of New York City and Washington, D.C. into a surreal...
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the way for...
110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800
Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO
110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800
Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO
CEO North America © 2024 - Sitemap